APA (7th ed.) Citation

Chu, W., Xu, H., Wang, Y., Xie, Y., Chen, Y., Tan, X., . . . Wang, C. (2022). HER2/PD1 bispecific antibody in IgG4 subclass with superior anti‐tumour activities. Clinical & Translational Medicine, 12(4), 1. https://doi.org/10.1002/ctm2.791

Chicago Style (17th ed.) Citation

Chu, Wendi, et al. "HER2/PD1 Bispecific Antibody in IgG4 Subclass with Superior Anti‐tumour Activities." Clinical & Translational Medicine 12, no. 4 (2022): 1. https://doi.org/10.1002/ctm2.791.

MLA (9th ed.) Citation

Chu, Wendi, et al. "HER2/PD1 Bispecific Antibody in IgG4 Subclass with Superior Anti‐tumour Activities." Clinical & Translational Medicine, vol. 12, no. 4, 2022, p. 1, https://doi.org/10.1002/ctm2.791.